GFAP and anxiety disorder: Serum glial fibrillary acidic protein (GFAP), a peripheral biomarker of astrocyte activation, has been shown to both reflect the degree of astrocyte-mediated neuroinflammation and correlate with the pathogenesis of anxiety disorders (20–22).